3-(aminomethyl)-N-(4-(trifluoromethoxy)benzyl)benzamide

ID: ALA1090720

PubChem CID: 46884038

Max Phase: Preclinical

Molecular Formula: C16H15F3N2O2

Molecular Weight: 324.30

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NCc1cccc(C(=O)NCc2ccc(OC(F)(F)F)cc2)c1

Standard InChI:  InChI=1S/C16H15F3N2O2/c17-16(18,19)23-14-6-4-11(5-7-14)10-21-15(22)13-3-1-2-12(8-13)9-20/h1-8H,9-10,20H2,(H,21,22)

Standard InChI Key:  SQZNQEBXRDPVMI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 24  0  0  0  0  0  0  0  0999 V2000
   14.6569   -3.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6557   -4.3398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3706   -4.7527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0870   -4.3394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0841   -3.5088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3688   -3.0997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9423   -3.1001    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2280   -3.5128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5134   -3.1005    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.2282   -4.3378    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.0142   -2.7160    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.8021   -4.7507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5159   -4.3371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2311   -4.7485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9451   -4.3343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2324   -5.5735    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6598   -4.7474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3734   -4.3339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3722   -3.5076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6514   -3.0965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9409   -3.5123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6469   -2.2715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3591   -1.8551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  2  0
  4 12  1  0
  6  1  1  0
 12 13  1  0
  1  2  2  0
 13 14  1  0
  1  7  1  0
 15 14  1  0
  3  4  2  0
 14 16  2  0
  7  8  1  0
 15 17  2  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  2  0
 21 15  1  0
  2  3  1  0
 20 22  1  0
  8 11  1  0
 22 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1090720

   3-(aminomethyl)-N-(4-(trifluoromethoxy)benzyl)benzamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 324.30

Molecular Weight (Monoisotopic): 324.1086

AlogP: 2.97

#Rotatable Bonds: 5

Polar Surface Area: 64.35

Molecular Species: BASE

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.80

CX LogP: 3.33

CX LogD: 1.92

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.89

Np Likeness Score: -1.30

References

1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB..  (2010)  Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.,  20  (7): [PMID:20202843] [10.1016/j.bmcl.2010.01.107]

Source

Source(1):

• Scientific Literature